Health and Healthcare

Merck : MRK

All Merck Articles

1084 Articles

Jon C. Ogg | Aug 8, 2016 at 12:45 PM EDT

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Credit Suisse sees the Bristol-Myers Squibb gap with Merck getting even worse, even though it still has robust I-O franchise…

Paul Ausick | Aug 5, 2016 at 4:01 PM EDT

Merck Dominates DJIA Boost Friday

August 5, 2016: Markets opened higher Friday following the report of 255,000 new U.S. jobs added in July. The financial…

Chris Lange | Aug 5, 2016 at 10:35 AM EDT

Why Bristol-Myers Failure Is a Huge Win for Merck

Bristol-Myers Squibb shares took a nosedive early Friday's following an update in its late-stage Checkmate trial. But Bristol-Myer's failure was…

Paul Ausick | Jul 29, 2016 at 8:20 AM EDT

Merck Raises EPS Outlook After Q2 Earnings

Merck reported better-than-expected second-quarter 2016 results before markets opened Friday morning.

Chris Lange | Jul 27, 2016 at 8:25 AM EDT

Short Sellers Get Selective on Major Pharma

The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest…

Chris Lange | Jul 24, 2016 at 10:50 AM EDT

Top Dow Earnings for the Week Ahead

Overall, one-third of the Dow Jones Industrial Average is reporting this week, and this has the potential to sustain the…

Chris Lange | Jul 13, 2016 at 9:15 AM EDT

Short Sellers Run for Cover From Major Pharma

The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Paul Ausick | Jul 6, 2016 at 4:01 PM EDT

The 4 Stocks That Lifted the DJIA Wednesday

July 6, 2016: Markets opened lower again Wednesday, following international markets that traded lower overnight. The British pound posted a…

Chris Lange | Jul 3, 2016 at 7:38 AM EDT

How Major Pharma Is Faring After the Brexit

The broad markets are recovering in the wake of the Brexit and it really appears to be one big head…

Paul Ausick | Jun 29, 2016 at 4:01 PM EDT

The 4 Stocks That Boosted the Dow Wednesday

June 29, 2016: Markets opened higher again Wednesday and every sector is again posting a gain as the closing bell…

Chris Lange | Jun 27, 2016 at 8:11 AM EDT

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The short interest data have been released for the June 15 settlement date. Pharmaceutical companies usually are involved in a…

Paul Ausick | Jun 17, 2016 at 4:01 PM EDT

The 4 Stocks That Tanked the Dow on Friday

June 17, 2016: Markets opened lower again Friday after a somewhat disappointing report on U.S. housing starts. St. Louis Fed…

Paul Ausick | Jun 16, 2016 at 4:01 PM EDT

The 4 Stocks That Lifted the Dow on Thursday

June 16, 2016: Markets opened lower Thursday but equities showed some spunk by trading on an upward trend for nearly…

Chris Lange | Jun 10, 2016 at 11:05 AM EDT

Merck Moves to Acquire Afferent Pharma

Merck and Afferent Pharmaceuticals reportedly have signed a definitive agreement under which the former will acquire the latter.

Chris Lange | Jun 10, 2016 at 8:05 AM EDT

Major Pharma Has Short Sellers on the Run

The May 31 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

1 … 35 36 37 38 39 … 73

Merck : MRK

All Merck Articles

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Merck Dominates DJIA Boost Friday

Why Bristol-Myers Failure Is a Huge Win for Merck

Merck Raises EPS Outlook After Q2 Earnings

Short Sellers Get Selective on Major Pharma

Top Dow Earnings for the Week Ahead

Short Sellers Run for Cover From Major Pharma

The 4 Stocks That Lifted the DJIA Wednesday

How Major Pharma Is Faring After the Brexit

The 4 Stocks That Boosted the Dow Wednesday

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The 4 Stocks That Tanked the Dow on Friday

The 4 Stocks That Lifted the Dow on Thursday

Merck Moves to Acquire Afferent Pharma

Major Pharma Has Short Sellers on the Run

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Merck : MRK

All Merck Articles

Why Credit Suisse Sees Merck and Bristol-Myers Gap Widening Further

Merck Dominates DJIA Boost Friday

Why Bristol-Myers Failure Is a Huge Win for Merck

Merck Raises EPS Outlook After Q2 Earnings

Short Sellers Get Selective on Major Pharma

Top Dow Earnings for the Week Ahead

Short Sellers Run for Cover From Major Pharma

The 4 Stocks That Lifted the DJIA Wednesday

How Major Pharma Is Faring After the Brexit

The 4 Stocks That Boosted the Dow Wednesday

Short Sellers Increase Bets Against Major Pharmaceutical Stocks

The 4 Stocks That Tanked the Dow on Friday

The 4 Stocks That Lifted the Dow on Thursday

Merck Moves to Acquire Afferent Pharma

Major Pharma Has Short Sellers on the Run

Google vs Apple: Which of the 2 Biggest AI Stocks Is the Better Buy Right Now?

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It

Featured Reads

The 20% Tax Credit Developers Use to Flip Historic Buildings and How You Can Claim It

Your RV Qualifies for the Same Mortgage Interest Deduction as a House, but Most Owners Never Claim It